Navigation Links
Spectral announces 2008 financial results
Date:3/12/2009

---------------------- Spectral Diagnostics Inc. Statements of Operations, Comprehensive Loss and Deficit For the years ended December 31, 2008 and 2007 ------------------------------------------------------------------------- (in thousands of dollars, except share and per share data) 2008 2007 $ $ Sales 3,011 2,993 Cost of sales 796 855 ---------------------------- Gross margin 2,215 2,138 ---------------------------- Operating expenses Selling, general and administrative 3,264 3,167 Amortization 592 536 Foreign exchange (gain) loss (117) 102 Stock-based compensation 110 117 Research and product development, net of tax credits 32 (59) ---------------------------- 3,881 3,863 ---------------------------- Loss before the following (1,666) (1,725) Interest expense on convertible notes payable (164) (165) Other net interest income 328 224 ---------------------------- Loss and comprehensive loss for the year (1,502) (1,666) Deficit - Beginn
'/>"/>
SOURCE Spectral Diagnostics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Spectral signs exclusive license agreement to bring sepsis therapeutic to the U.S. market
2. Surface plasmon resonances of metal nanoparticles in array can have narrower spectral widths
3. Spectral announces third quarter 2008 results
4. Spectral to bring anti-sepsis therapy to the U.S. market
5. Spectral announces exclusive distribution agreement in Russia for its EAA(TM) Sepsis Diagnostic Assay
6. Spectral announces continuing support for the combination of EAA(TM) and anti-endotoxin therapeutics
7. Spectral announces presentation of data on improving sepsis patient management with EAA(TM) and Toraymyxin(TM) combination
8. Spectral and Toray expand collaboration to include new geographic territories
9. Spectrals EAA(TM) to be used in Phase III study for a sepsis anti-endotoxin therapy
10. Spectral announces new findings on the effectiveness of EAA(TM)/Toraymyxin(TM) at the 28th International Symposium on Intensive Care and Emergency Medicine
11. Spectral announces 2007 financial results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 This webinar will ... and clinical safety assessment in biosimilars. , Regulatory frameworks ... biosimilar drug development, however the complex nature of biopharmaceuticals ... safety and efficacy extremely challenging. Based on the specific ...
(Date:1/15/2014)... 2014 DTS Language Services, Inc . ... Portal for Life Science organizations who need document translations. ... matter of their documents in advance with a selection of ... of translations, often a critical factor in clinical and scientific ...
(Date:1/14/2014)... 14, 2014 Date: Friday, April 11, 2014 ... Country Club, 1360 Almshouse Road, Warrington, Pa. , ... solely dedicated to finding a cure for hepatitis B and ... host its annual Crystal Ball on Friday, April 11 at ...
(Date:1/14/2014)... EquitiesIQ, a leading informational research provider, ... is an emerging biomedical company acquiring, developing, manufacturing, and ... , Free report download: http://equitiesiq.com/reports/alliqua/ , In ... team and Board, which launched the company’s new strategy ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... to provide high coverage and megabase capacity for ... Germany, March 16 febit today ... capture technology HybSelect. In several biomedical studies of ... demonstrated superb enrichment factors and deep sequencing coverage ...
... Outstanding Indevus Shares Have Been Accepted for PurchaseCHADDS ... ENDP ) announced today that, as ... March 13, 2009, approximately 71,008,964 shares (including shares ... tendered and accepted for purchase in the tender ...
... - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ... reovirus (REOLYSIN(R)) are available on the American Association for ... on the Oncolytics website at www.oncolyticsbiotech.com . The ... AACR Annual Meeting in Denver, Colorado, April 18-22, 2009. ...
Cached Biology Technology:Automated Sequence Capture for Next-Generation Sequencing Paves the Way for Personalized Medicine 2Automated Sequence Capture for Next-Generation Sequencing Paves the Way for Personalized Medicine 3Endo Pharmaceuticals Extends Subsequent Offering Period for Indevus Shares Until 5:00 pm EDT on Wednesday, March 18, 2009 2Endo Pharmaceuticals Extends Subsequent Offering Period for Indevus Shares Until 5:00 pm EDT on Wednesday, March 18, 2009 3Oncolytics Biotech(R) Inc. Announces Reovirus Research to be Presented at AACR Annual Meeting 2Oncolytics Biotech(R) Inc. Announces Reovirus Research to be Presented at AACR Annual Meeting 3
(Date:4/17/2014)... need to produce hydrogen sulfide in order to properly ... study from the Center for Craniofacial Molecular Biology at ... Professor Songtao Shi, principal investigator on the project, said ... governs the flow of calcium ions. The essential ions ... osteogenesis, or the creation of new bone tissue, and ...
(Date:4/17/2014)... White House honored Clemson professor Rajendra Singh Thursday ... to promote and expand solar deployment in the ... D. Houser Banks Professor of Electrical and Computer ... Nanoelectronics, is considered a local hero leading the ... economic opportunity in solar power and driving policy ...
(Date:4/17/2014)... that devastate honeybees in Europe, Asia and the United ... appear to be impacting native honeybee populations at this ... invasive pests include including Nosema microsporidia and ... to be resilient to these invasive pests, which suggests ... in Europe, Asia and the United States currently are ...
Breaking Biology News(10 mins):White House honors Clemson professor as 'Champion of Change' for solar deployment 2East African honeybees are safe from invasive pests… for now 2East African honeybees are safe from invasive pests… for now 3
... researchers has completed a first draft of the cassava (Manihot ... accelerating the pace of research on this subsistence crop and ... around the world. Cassava is a root crop that ... million people each day. Although it has many properties that ...
... Scientists and industry leaders from around the world will ... Molecular Targets and Cancer Therapeutics International Conference, which will ... "Cancer is a complex disease and to ... the activity that takes place at the molecular level," ...
... open for the Society of Interventional Radiology,s "Image-guided ... the latest updates on percutaneous and transcatheter treatment ... tumor ablation. SIR is a national organization of ... improving public health through pioneering advances in image-guided ...
Cached Biology News:Researchers complete draft genome sequence for cassava 2Researchers complete draft genome sequence for cassava 3Researchers complete draft genome sequence for cassava 4Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2
Request Info...
Guinea Pig Complement...
Collected from 8-12 week-old New Zealand or Californian rabbits....
Enables rapid purification of double-stranded DNA fragments = 200 bp, including, for example, PCR reaction products, DNA fragments obtained in restriction enzyme digests, or double-stranded cDNA...
Biology Products: